Roche Holding AG
RO.SWSMI
358,60 CHF
Dividend yield3,01 %
Continuity33 yr
Dividend10,80 CHF
DiviScore
GoodPerformance19/35
Dividend Quality29/35
AGM Date
—Ex-Date
12.03.2026Payment
—CAGR 3Y
+7.5%CAGR 5Y
-1.6%CAGR 10Y
+3.7%€10,000 invested in 2016 · with dividend reinvestment
End Value
19.736,30 CHF
Total Return
+97.4%
Annual Return
7.0% p.a.
Dividends Received
4.278,45 CHF
Dividend history
About Roche Holding AG
Roche, based in Basel and family-controlled, is a global leader in pharmaceuticals and diagnostics, best known for cancer medicines and the world's largest in-vitro diagnostics business. That combination of drugs and testing gives it a broad, resilient healthcare franchise, even as some older blockbusters face biosimilar competition. Roche has raised its dividend for around three decades without a cut, one of the longest streaks in Europe, funded by dependable cash flow. A reliable, growing payout from a defensive healthcare leader makes it a cornerstone income holding.
Frequently Asked Questions
The next payment date is not yet announced.
Roche Holding AG has a DiviScore of 73/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
Roche Holding AG's current dividend yield is 3.01% based on the latest dividend.
Roche Holding AG (RO.SW) is a member of SMI. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.